Qingdao Haier Financials
| 688139 Stock | 35.20 0.00 0.00% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 306.7 M | 394.5 M |
|
|
Qingdao | Select Account or Indicator |
Understanding current and past Qingdao Haier Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Qingdao Haier's financial statements are interrelated, with each one affecting the others. For example, an increase in Qingdao Haier's assets may result in an increase in income on the income statement.
Please note, the presentation of Qingdao Haier's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Qingdao Haier's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Qingdao Haier's management manipulating its earnings.
Qingdao Haier Stock Summary
Qingdao Haier competes with Sanbo Hospital, Zhengping RoadBridge, Chengdu Xinzhu, Chengdu Spaceon, and Hubeiyichang Transportation. Qingdao Haier is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE100003P25 |
| Business Address | No 280 Feng |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.haierbiomedical.com |
| Phone | 86 532 8893 5566 |
You should never invest in Qingdao Haier without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Qingdao Stock, because this is throwing your money away. Analyzing the key information contained in Qingdao Haier's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Qingdao Haier Key Financial Ratios
Qingdao Haier's financial ratios allow both analysts and investors to convert raw data from Qingdao Haier's financial statements into concise, actionable information that can be used to evaluate the performance of Qingdao Haier over time and compare it to other companies across industries.| Revenue | 2.28 B | ||||
| Gross Profit | 1.38 B | ||||
| EBITDA | 398.4 M | ||||
| Net Income | 406.07 M | ||||
| Total Asset | 5.53 B |
Qingdao Haier Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 3.9B | 4.9B | 5.5B | 5.5B | 6.4B | 3.7B | |
| Other Current Liab | 386.9M | 514.2M | 14.4M | 8.7M | 7.8M | 7.5M | |
| Other Liab | 35.3M | 113.7M | 113.3M | 145.5M | 167.3M | 175.7M | |
| Net Tangible Assets | 1.1B | 2.4B | 2.2B | 3.1B | 3.5B | 1.8B | |
| Retained Earnings | 584.3M | 1.3B | 1.8B | 1.9B | 2.1B | 2.2B | |
| Accounts Payable | 448.1M | 431.6M | 485.1M | 391.0M | 449.6M | 366.3M | |
| Cash | 1.8B | 774.4M | 951.8M | 1.3B | 1.5B | 949.4M | |
| Other Assets | 24.8M | 37.6M | 65.4M | 55.5M | 63.8M | 42.2M | |
| Net Receivables | 135.0M | 112.3M | 155.8M | 187.7M | 215.8M | 167.2M | |
| Good Will | 323.9M | 323.5M | 451.3M | 642.7M | 739.1M | 776.0M | |
| Inventory | 247.9M | 345.7M | 270.5M | 248.0M | 285.2M | 187.3M | |
| Other Current Assets | 25.4M | 38.2M | 8.2M | 132.8M | 152.7M | 160.3M | |
| Total Liab | 1.2B | 1.3B | 1.3B | 1.1B | 1.2B | 1.0B | |
| Short Long Term Debt | 31.8M | 9.9M | 25.2M | 20.8M | 18.7M | 17.8M | |
| Total Current Assets | 2.7B | 3.5B | 3.5B | 2.5B | 2.9B | 2.6B | |
| Intangible Assets | 214.6M | 241.6M | 312.3M | 367.7M | 422.9M | 444.0M | |
| Net Invested Capital | 2.8B | 3.6B | 4.0B | 4.3B | 4.9B | 3.1B | |
| Net Working Capital | 1.7B | 2.3B | 2.3B | 1.6B | 1.8B | 1.8B |
Qingdao Haier Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | 40.1M | 111.7M | 63.4M | 22.4M | 25.8M | 45.9M | |
| Net Interest Income | 22.9M | 7.7M | 16.7M | 31.3M | 35.9M | 37.7M | |
| Interest Expense | 83.4K | 2.9M | 2.7M | 3.5M | 3.2M | 4.2M | |
| Total Revenue | 1.4B | 2.1B | 2.9B | 2.3B | 2.6B | 1.6B | |
| Gross Profit | 707.9M | 1.1B | 1.4B | 1.2B | 1.3B | 806.0M | |
| Operating Income | 321.7M | 463.5M | 594.5M | 343.1M | 394.5M | 306.7M | |
| Ebit | 102.2M | 196.6M | 303.0M | 442.0M | 508.3M | 533.7M | |
| Research Development | 150.7M | 236.3M | 292.5M | 320.6M | 368.7M | 387.2M | |
| Cost Of Revenue | 694.1M | 1.1B | 1.5B | 1.1B | 1.3B | 793.2M | |
| Income Before Tax | 424.2M | 960.9M | 675.3M | 434.5M | 499.7M | 422.5M | |
| Net Income | 381.0M | 845.0M | 600.8M | 406.1M | 467.0M | 373.0M | |
| Income Tax Expense | 27.7M | 40.1M | 111.7M | 63.4M | 72.9M | 49.0M | |
| Minority Interest | 8.6M | (4.1M) | (11.2M) | (6.0M) | (5.4M) | (5.1M) | |
| Interest Income | 23.2M | 10.7M | 20.3M | 35.6M | 41.0M | 43.0M | |
| Ebitda | 222.8M | 447.2M | 1.0B | 742.1M | 853.4M | 496.4M |
Qingdao Haier Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Qingdao Haier Biomedical. It measures of how well Qingdao is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Qingdao Haier brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Qingdao had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Qingdao Haier has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (115.6M) | (99.1M) | 76.8M | 38.3M | 44.1M | 46.3M | |
| Investments | 320.4M | (1.8B) | 66.0M | 252.8M | 290.7M | 305.2M | |
| Change In Cash | 414.9M | (1.0B) | 183.9M | 325.5M | 374.3M | 393.0M | |
| Depreciation | 22.9M | 48.3M | 64.1M | 102.7M | 118.1M | 124.0M | |
| Capital Expenditures | 89.0M | 204.7M | 294.2M | 177.2M | 203.8M | 143.6M | |
| Net Income | 381.0M | 845.0M | 600.8M | 406.1M | 467.0M | 373.0M | |
| End Period Cash Flow | 1.8B | 747.2M | 931.2M | 1.3B | 1.4B | 920.5M | |
| Change To Netincome | (14.5M) | 26.6M | (82.5M) | (483.6M) | (435.3M) | (413.5M) | |
| Free Cash Flow | 607.6M | 387.1M | 338.2M | 72.1M | 82.9M | 78.8M | |
| Other Non Cash Items | 428.5K | (1.5M) | 668.8K | (9.3M) | (8.4M) | (7.9M) | |
| Dividends Paid | 57.1M | 120.8M | 162.5M | 142.8M | 128.5M | 114.2M |
Qingdao Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Qingdao Haier's current stock value. Our valuation model uses many indicators to compare Qingdao Haier value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Qingdao Haier competition to find correlations between indicators driving Qingdao Haier's intrinsic value. More Info.Qingdao Haier Biomedical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.40 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Qingdao Haier Biomedical is roughly 2.50 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Qingdao Haier by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Qingdao Haier's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Qingdao Haier Biomedical Systematic Risk
Qingdao Haier's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Qingdao Haier volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Qingdao Haier Biomedical correlated with the market. If Beta is less than 0 Qingdao Haier generally moves in the opposite direction as compared to the market. If Qingdao Haier Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Qingdao Haier Biomedical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Qingdao Haier is generally in the same direction as the market. If Beta > 1 Qingdao Haier moves generally in the same direction as, but more than the movement of the benchmark.
Qingdao Haier Biomedical Total Assets Over Time
Qingdao Haier Thematic Clasifications
Qingdao Haier Biomedical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Qingdao Haier January 4, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Qingdao Haier help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Qingdao Haier Biomedical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Qingdao Haier Biomedical based on widely used predictive technical indicators. In general, we focus on analyzing Qingdao Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Qingdao Haier's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.54 | |||
| Information Ratio | 0.135 | |||
| Maximum Drawdown | 27.16 | |||
| Value At Risk | (5.34) | |||
| Potential Upside | 8.65 |
Complementary Tools for Qingdao Stock analysis
When running Qingdao Haier's price analysis, check to measure Qingdao Haier's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Qingdao Haier is operating at the current time. Most of Qingdao Haier's value examination focuses on studying past and present price action to predict the probability of Qingdao Haier's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Qingdao Haier's price. Additionally, you may evaluate how the addition of Qingdao Haier to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |